Of note, while the affinity for D2 and 5-HT2A receptors is a crucial feature of atypical antipsychotics, targeting 5-HT1A and 5-HT7 receptors have been variously correlated to beneficial effects in the context of psychosis [13,14]. The gene discussed is HTR1A; the disease is psychotic disorder.